Abstract
Despite significant advancement in primary percutaneous interventions, cardiogenic shock (CS) remains a clinical challenge in patients with ischemic cardiomyopathy (ICM). Percutaneous mechanical circulatory support devices (MCS) have been increasingly utilized and have become an essential component
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have